NIH clinical trials protocol template

NIH clinical trials protocol template

Every clinical investigation begins with the development of a clinical protocol. The protocol is a document that describes how a clinical trial will be conducted (the objective(s), design, methodology, statistical considerations and organization of a…

Clinical trials specialist NIH

Clinical trials specialist NIH

Graduate Medical Education (GME): Rheumatology James Katz, MD Eligibility Criteria Applicants must have completed two or more years of internal medicine residency training. Residents in the American Board of Internal Medicine Clinical Investigator Pathway…

NIHR clinical trials Fellowships

NIHR clinical trials Fellowships

Many of the research studies we commission involve clinical trials. The conduct and execution of well designed trials requires partnership with clinicians, other trialists and methodologists and ideally builds on the experience, expertise and infrastructure…

NIH clinical trials lymphoma

NIH clinical trials lymphoma

Patients with a type of cancer known as primary mediastinal B-cell lymphoma who received infusions of chemotherapy, but who did not have radiation therapy to an area of the thorax known as the mediastinum, had excellent outcomes, according to clinical…

NIH clinical Trial Planning Grant

NIH clinical Trial Planning Grant

NIDCR CLINICAL TRIAL PLANNING GRANT Release Date: August 23, 1 (see replacement PAR-03-042) PA NUMBER: PAR-99-157 National Institute of Dental and Craniofacial Research THIS PA USES THE MODULAR GRANT AND JUST-IN-TIME CONCEPTS. IT INCLUDES DETAILED…

NIH COPD clinical trials

NIH COPD clinical trials

COPD is the third leading cause of death nationwide. It’s often brought on by cigarette smoking. COPD can cause shortness of breath, wheezing and coughing, among other symptoms. In patients with COPD, immune cells called macrophages lose their ability…

NIH clinical trials sarcoidosis

NIH clinical trials sarcoidosis

The National Heart, Lung, and Blood Institute (NHLBI), the National Institute of Allergy and Infectious Diseases (NIAID), and the Office of Rare Diseases (ORD) convened a workshop on July 25, 2008 to review the studies conducted in the last 10 years in…